Supreme court denies caredx request for appeal in patent case with natera

Austin, texas--(business wire)--natera, inc. (nasdaq: ntra), a global leader in cell-free dna (cfdna) testing, today announced that the united states supreme court denied caredx, inc.'s (nasdaq: cdna) petition for certiorari concerning a patent infringement lawsuit brought by caredx against natera. this decision confirms the invalidity of the patents asserted against natera and follows three previous rulings on the matter: a september 2021 decision by the united states district court for the di.
CDNA Ratings Summary
CDNA Quant Ranking